10 January 2019 - - Denmark-based medical dermatology company Leo Pharma has appointed Adam B. Raff as director and medical advisor in translational medicine as of January 28, 2019, the company said.

Adam Raff's primary objective will be to support Leo Pharma's ambitions to advance science within dermatology through translational medicine.

Adam Raff is a Doctor of Medicine and holds a Doctorate in Philosophy in Systems Biology and Disease from the University of Southern California in Los Angeles, CA as well as a Bachelor of Science in Biology from Georgetown University in Washington, DC.

He completed his dermatology training at the Harvard Combined Dermatology Residency Program, Boston, MA.

In his current position, Adam Raff works as a dermatologist at the Department of Dermatology at Massachusetts General Hospital, Boston, MA as well as a Dermatology Instructor at Harvard Medical School, Boston, MA.

With the addition of a new Translational Medicine Unit in Boston, Leo Pharma is taking another important step towards realising its mission of helping people achieve healthy skin by addressing high unmet needs.

The aim of Leo Pharma is to take the global lead in translational dermatology and immunology, among other by strengthening the way the company uses novel technologies in building a precision medicine platform, and by translating scientific and patient insights to further build the company's disease understanding.